Speech-Language Pathologists in Hoopeston, IL Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Mrs. Callie Grace Lankford, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325 E Orange St, Hoopeston, IL 60942 Phone: 217-497-6043

Katherine C Clayton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19946 E 4000 North Rd, Hoopeston, IL 60942 Phone: 217-339-2326

Hayley Hambleton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 S 4th St, Hoopeston, IL 60942 Phone: 217-495-2080

News Archive

International Harm Reduction Conference to focus on HIV/AIDS epidemic

Injecting drug use and growing HIV/AIDS epidemic in Middle East and North Africa region to be focus of the International Harm Reduction conference taking place in Beirut, Lebanon April 3-7 2011

FDA Warning Letter for Deconsal: Cornerstone Therapeutics preparing a response

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today reported that it had received a Warning Letter from the Food and Drug Administration ("FDA") alleging that its Deconsal CT chewable tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg) and Deconsal DM chewable tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg, Dextromothorphan HBr 15 mg) are new drugs lacking an approved application and as such should not be introduced into interstate commerce.

EnGeneIC plans for Phase 2a trial of EGFR-targeted doxorubicin-packaged EDV nanocells for GBM

EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, today announced plans to move forward with a Phase 2a clinical trial in the U.S. using its formulation of EGFR-targeted, EDV nanocells packaged with doxorubicin for the treatment of recurrent glioblastoma (GBM), a common and aggressive type of brain tumor.

NCCC offers new heart sparing treatment for left breast cancer

Norris Cotton Cancer Center (NCCC) offers a new heart sparing treatment for left breast cancer to women concerned about radiation and increased heart disease risk. NCCC was the first tertiary academic medical center in New Hampshire to offer the technique, Deep Inspiration Breath Hold (DIBH), to patients.

New pilot study shows little difference in digestibility between raw milk and pasteurized milk

Some sour news for lactose-intolerant people who hoped that raw milk might prove easier to stomach than pasteurized milk: A pilot study from the Stanford University School of Medicine shows little difference in digestibility between the two.

Read more Medical News

› Verified 5 days ago